LRT Capital Management LLC Buys Stake in Eli Lilly

Investment firm acquires 861 shares of pharmaceutical giant in Q3

Mar. 17, 2026 at 10:12am

Got story updates? Submit your updates here. ›

LRT Capital Management LLC, a hedge fund, acquired a new position in shares of Eli Lilly and Company (NYSE:LLY) during the third quarter of 2026. The firm purchased 861 shares of the company's stock, valued at approximately $657,000.

Why it matters

Eli Lilly is one of the world's largest pharmaceutical companies, known for developing and commercializing a broad range of medicines and therapies. This investment by LRT Capital Management suggests the firm sees growth potential in Lilly's business and stock.

The details

According to the report, a number of other hedge funds have also made changes to their positions in Lilly. Vanguard Group Inc. boosted its stake in the company by 0.7% during the third quarter, now owning 80,959,089 shares. Capital Research Global Investors grew its holdings in Lilly by 20.9%, now holding 25,088,371 shares. Wellington Management Group LLP increased its position in Lilly by 4.1%, now owning 14,563,780 shares.

  • LRT Capital Management LLC acquired the new position in Eli Lilly and Company during the 3rd quarter of 2026.

The players

LRT Capital Management LLC

A hedge fund that acquired a new position in shares of Eli Lilly and Company.

Eli Lilly and Company

A global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. The company researches, develops, manufactures and commercializes a broad range of medicines and therapies for patients worldwide.

Vanguard Group Inc.

An investment management company that boosted its stake in Eli Lilly and Company by 0.7% during the third quarter.

Capital Research Global Investors

An investment firm that grew its holdings in Eli Lilly and Company by 20.9% during the third quarter.

Wellington Management Group LLP

An investment management company that increased its position in Eli Lilly and Company by 4.1% during the third quarter.

Got photos? Submit your photos here. ›

The takeaway

This investment by LRT Capital Management in Eli Lilly highlights the pharmaceutical company's continued appeal to institutional investors, as major firms increase their stakes in the company amid its growth and product pipeline.